Vikram Patel
Auto-generated profile, based on publicly available information

Vikram Patel

Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Lancet
Verified
Journal Article
Open access
VPVikram Patel
Vikram Patel
SSShekhar Saxena
Shekhar Saxena
CLCrick Lund
Crick Lund
GTGraham Thornicroft
Graham Thornicroft
FBFlorence Baingana
Florence Baingana
JUJürgen Unützer
Jürgen Unützer

1 September 2007 in The Lancet
Verified
Journal Article
Closed access
SMSaba Moussavi
Saba Moussavi
SCSomnath Chatterji
Somnath Chatterji
EVEmese Verdes
Emese Verdes
ATAjay Tandon
Ajay Tandon
VPVikram Patel
Vikram Patel
BUBedirhan Ustun
Bedirhan Ustun

1 September 2007 in The Lancet
Verified
Journal Article
Closed access
MPMartin Prince
Martin Prince
VPVikram Patel
Vikram Patel
SSShekhar Saxena
Shekhar Saxena
MMMario Maj
Mario Maj
JMJoanna Maselko
Joanna Maselko
ARAtif Rahman
Atif Rahman

1 April 2007 in The Lancet
Verified
Journal Article
Closed access
VPVikram Patel
Vikram Patel
AFAlan J Flisher
Alan J Flisher
SHSarah Hetrick
Sarah Hetrick
PMPatrick McGorry
Patrick McGorry

19 March 2014 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
ZSZachary Steel
Zachary Steel
CMClaire Marnane
Claire Marnane
CIChangiz Iranpour
Changiz Iranpour
TCTien Chey
Tien Chey
JJJohn W Jackson
John W Jackson
DSDerrick Silove
Derrick Silove
Background: Since the introduction of specified diagnostic criteria for mental disorders in the 1970s, there has been a rapid expansion in the number of large-scale mental health surveys providing population estimates of the combined prevalence of common mental disorders (most commonly involving mood, anxiety and substance use disorders). In this study we undertake a systematic review and meta-analysis of this literature. Methods: We applied an optimized search strategy across the Medline, PsycINFO, EMBASE and PubMed databases, supplemented by hand searching to identify relevant surveys. We identified 174 surveys across 63 countries providing period prevalence estimates (155 surveys) and lifetime prevalence estimates (85 surveys). Random effects meta-analysis was undertaken on logit-transformed prevalence rates to calculate pooled prevalence estimates, stratified according to methodological and substantive groupings. Results: Pooling across all studies, approximately 1 in 5 respondents (17.6%, 95% confidence interval:16.3–18.9%) were identified as meeting criteria for a common mental disorder during the 12-months preceding assessment; 29.2% (25.9–32.6%) of respondents were identified as having experienced a common mental disorder at some time during their lifetimes. A consistent gender effect in the prevalence of common mental disorder was evident; women having higher rates of mood (7.3%:4.0%) and anxiety (8.7%:4.3%) disorders during the previous 12 months and men having higher rates of substance use disorders (2.0%:7.5%), with a similar pattern for lifetime prevalence. There was also evidence of consistent regional variation in the prevalence of common mental disorder. Countries within North and South East Asia in particular displayed consistently lower one-year and lifetime prevalence estimates than other regions. One-year prevalence rates were also low among Sub-Saharan-Africa, whereas English speaking counties returned the highest lifetime prevalence estimates. Conclusions: Despite a substantial degree of inter-survey heterogeneity in the meta-analysis, the findings confirm that common mental disorders are highly prevalent globally, affecting people across all regions of the world. This research provides an important resource for modelling population needs based on global regional estimates of mental disorder. The reasons for regional variation in mental disorder require further investigation.

11 April 2012 in Autism Research
Verified
Journal Article
Open access
PDF file
MEMayada Elsabbagh
Mayada Elsabbagh
GDGauri Divan
Gauri Divan
YKYun‐Joo Koh
Yun‐Joo Koh
YKYoung Shin Kim
Young Shin Kim
SKShuaib Kauchali
Shuaib Kauchali
EFEric Fombonne
Eric Fombonne
We provide a systematic review of epidemiological surveys of autistic disorder and pervasive developmental disorders (PDDs) worldwide. A secondary aim was to consider the possible impact of geographic, cultural/ethnic, and socioeconomic factors on prevalence estimates and on clinical presentation of PDD. Based on the evidence reviewed, the median of prevalence estimates of autism spectrum disorders was 62/10 000. While existing estimates are variable, the evidence reviewed does not support differences in PDD prevalence by geographic region nor of a strong impact of ethnic/cultural or socioeconomic factors. However, power to detect such effects is seriously limited in existing data sets, particularly in low‐income countries. While it is clear that prevalence estimates have increased over time and these vary in different neighboring and distant regions, these findings most likely represent broadening of the diagnostic concets, diagnostic switching from other developmental disabilities to PDD, service availability, and awareness of autistic spectrum disorders in both the lay and professional public. The lack of evidence from the majority of the world's population suggests a critical need for further research and capacity building in low‐ and middle‐income countries. Autism Res 2012, 5: 160–179. © 2012 International Society for Autism Research, Wiley Periodicals, Inc.